Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer

NCT05377788 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT05377788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05377788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2022
Completion date
June 30, 2024
Enrollment
900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

egfr t790m, metastatic lung non-small cell carcinoma